GALMED PHARMACEUTICALS LTD. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
GALMED PHARMACEUTICALS LTD. (GLMD) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $5.09 million for the 6-month period ending 2017-06-30, per its 6-K filed 2017-07-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-07-31
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|
| 2017-06-30 | $5.09M 6-K · filed 2017-07-31 | |
| 2016-12-31 | $6.34M 20-F · filed 2017-03-23 | |
| 2016-06-30 | $5.01M 6-K · filed 2017-07-31 | |
| 2015-12-31 | -$11.11M 20-F · filed 2017-03-23 | |
| 2015-06-30 | -$12.43M 6-K · filed 2017-06-23 | |
| 2014-12-31 | -$9.02M 20-F · filed 2017-03-23 | |
| 2013-12-31 | $3.00K 20-F · filed 2016-03-22 | |
| 2012-12-31 | -$32.00K 20-F · filed 2015-03-31 |